North China Pharmaceutical Group Semisyntech

North China Pharmaceutical Group Semisyntech is an active Chinese pharmaceutical manufacturing subsidiary of the North China Pharmaceutical group focused primarily on semisynthetic penicillin and related beta-lactam active pharmaceutical ingredients. The company operates as a commercial-stage manufacturer rather than a clinical-stage biotech, with strengths in antibiotic APIs such as amoxicillin, ampicillin sodium, piperacillin sodium, procaine penicillin, and benzathine penicillin. It appears to serve both domestic and export markets and maintains GMP-regulated production capabilities, including certifications that support EU-facing supply. Publicly available information positions the company as one of China’s important production bases for semisynthetic penicillin APIs, with a notable share in the domestic amoxicillin market. The business is best understood as a manufacturing and industrial pharma entity within a larger state-owned pharmaceutical group, not as an innovation-led platform biotech with a disclosed novel-drug pipeline.